Vascarta Advances VAS-101 as Non-Opioid Pain Therapy
SUMMIT, N.J., August 25, 2026 Vascarta Inc. outlined new and previously generated preclinical and clinical evidence supporting the potential...
p38 MAPK
Advertisement
Advertisement
Advertisement
SUMMIT, N.J., August 25, 2026 Vascarta Inc. outlined new and previously generated preclinical and clinical evidence supporting the potential...
Advertisement